@bbcnews

BBC News · checked 1h ago

Public35.39 GB2,262 posts & reels4,080 changes

6 of 2,262

1080×1920 · 14.4 MB video + audio

video

The US Food and Drug Administration (FDA) told makers of popular weight-loss GLP-1 drugs that they must add warning labels about a rare eye condition that can cause sudden blindness. Manufacturers of Ozempic, Wegovy, Mounjaro and Zepbound must warn about nonarteritic anterior ischemic optic neuropathy (NAION). The disorder happens when vessels supplying blood to the optic nerves become blocked, depriving the nerves of oxygen. In a statement to the BBC, the American Academy of Ophthalmology said "any added risk appears small, and it has not been established that these medications cause NAION". Tap the link in @BBCNews’s bio to learn more. #BBCNews

Taken: 10 Nov 2026, 22:31:13
Likes: 11988
Comments: 387
Plays: 1,998,207
Duration: 60.0s
On Instagram: instagram.com/…-5uKDn6F
Shortcode: Dfk-5uKDn6F
pk: 4027620612230774405
On profiles: bbcnews